Company news
Immunovia Ab (OMXSTO:IMMNOV) news
Immunovia Ab news releases on 6ix. Latest, Aug 6, 2026: Immunovia Publishes Interim Report for April-June 2026
Press releases & updates
Immunovia Publishes Interim Report for April-June 2026
August 6, 2026
Immunovia announces new performance data for PancreaSure ahead of upcoming application for Medicare coverage
June 15, 2026
Immunovia publishes final AFFIRM study results in Journal of Clinical Oncology confirming strong diagnostic performance of PancreaSure
June 10, 2026
Immunovia Publishes Interim Report for January-March 2026
May 7, 2026
Immunovia launches ASSURE registry to evaluate real-world clinical impact of PancreaSure in high-risk pancreatic cancer surveillance
May 5, 2026
Immunovia : Proposal for resolution on (A) option program for board members; and (B) directed issue of warrants and approval of transfer of warrants (Proposal for resolution on A option program for board members and B directed issue of warrants and approval of transfer of warrants 45758458 v6)
May 4, 2026
Immunovia : Proposal for resolution on (A) option program for management and key persons; and (B) directed issue of warrants and approval of transfer of warrants (Proposal for resolution on A option program for management and key persons and B directed issue of warrants and approval of transfer of warrants)
April 14, 2026
Immunovia : Proposal for resolution on authorization of the board to resolve on new issue of shares (Proposal for resolution on authorization regarding issues)
April 14, 2026
Immunovia : Proposal for resolution on (A) option program for board members; and (B) directed issue of warrants and approval of transfer of warrants (Proposal for resolution on A option program for board members and B directed issue of warrants and approval of transfer of warrants )
April 14, 2026
Immunovia : Annual Report (Immunovia AB publ Annual Report 2025)
April 14, 2026
Immunovia : Statement from nomination committee (Statement from nomination committee 2026)
April 14, 2026
Immunovia : Notice to annual general meeting 2026 (notice of annual general meeting in immunovia ab publ)
April 14, 2026
Immunovia publishes the Annual Report for 2025
April 10, 2026
Immunovia : Remuneration Report (Remuneration Report 2026 Updated)
April 9, 2026
Immunovia Publishes Full Year Report for 2025
February 24, 2026
Immunovia : Invitation to presentation of Immunovia's Q4 2025 report
February 23, 2026
Immunovia receives state regulatory approval for PancreaSure in California and initiates commercial rollout
January 19, 2026